SUNSHINE BIOPHARMA RECEIVES NOTICE OF ALLOWANCE FOR A NEW PATENT[...]
SUNSHINE BIOPHARMA DISCUSSES THE PROGRESS OF ITS COVID-19 AND[...]
SUNSHINE BIOPHARMA RECEIVES RECENTLY ORDERED NEW BATCH OF ADVA-27A AND[...]
02/15/2022 | Press release | Archived content
Please select the service you want to use:
Smartlinks | Sunshine Biopharma Inc. | News | Health | Finance | Stock Markets | Security Markets | Stock Markets | Security Markets | Company News | Issue of Shares and Capital Increase | Public Share Offering | Securities Issuers | Pharmaceutical Companies | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact